Mesa Laboratories, Inc. Share Price
Stocks
MLAB
US59064R1095
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 105.48 USD | -1.74% |
|
+1.53% | +34.37% |
| Market Cap | 58Cr 50Cr 46Cr 43Cr 81Cr 5.54TCr 83Cr 547.67Cr 213.53Cr 2.7TCr 218.71Cr 214.06Cr 9.34TCr | P/E Ratio 2027 * |
77.6x | P/E Ratio 2028 * | 49.2x |
|---|---|---|---|---|---|
| Enterprise Value | 58Cr 50Cr 46Cr 43Cr 81Cr 5.54TCr 83Cr 547.67Cr 213.53Cr 2.7TCr 218.71Cr 214.06Cr 9.34TCr | EV / Sales 2027 * |
2.25x | EV / Sales 2028 * | 2.14x |
| Free-Float |
94.45% | Yield 2027 * |
0.61% | Yield 2028 * | 0.61% |
Last Transcript: Mesa Laboratories, Inc.
| 1 day | -1.74% | ||
| 1 week | +1.53% | ||
| Current month | +3.39% | ||
| 1 month | +4.96% | ||
| 3 months | +35.30% | ||
| 6 months | +35.63% | ||
| Current year | +34.37% |
| 1 week | 103.94 |  | 113.99 |
| 1 month | 81.3 | | 113.99 |
| Current year | 71.06 | | 113.99 |
| 1 year | 55.45 | | 113.99 |
| 3 years | 55.45 | | 155.12 |
| 5 years | 55.45 | | 333.42 |
| 10 years | 55.45 | | 333.42 |
| Manager | Title | Age | Since |
|---|---|---|---|
Siddhartha Kadia
CEO | Chief Executive Officer | 56 | 12/04/2026 |
John Sakys
DFI | Director of Finance/CFO | 57 | 29/10/2012 |
Paul Yates
PRN | Corporate Officer/Principal | - | 01/05/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
John Sullivan
CHM | Chairman | 73 | 01/09/2017 |
Mark Capone
BRD | Director/Board Member | 63 | 05/01/2024 |
R. Tripeny
BRD | Director/Board Member | 67 | 23/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 14/04 | Free | Chief Executive Officer | 35,236 | 0.6378% | ||
| 31/03 | Issuer sale | Chief Executive Officer | 8,211 | 0.1486% | ||
| 10/03 | Buy | Director | 1,301 | 0.0235% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.74% | +1.53% | +8.63% | -22.36% | 58Cr | |
| -1.64% | -3.17% | -34.98% | -14.60% | 15TCr | |
| -0.16% | -1.80% | -8.10% | -8.77% | 10TCr | |
| +0.79% | +5.34% | +61.59% | +48.40% | 5.52TCr | |
| +0.07% | +2.41% | -4.69% | +57.31% | 5.48TCr | |
| -0.75% | -3.25% | -15.08% | -42.27% | 4.03TCr | |
| -1.40% | +8.93% | - | - | 3.1TCr | |
| +0.16% | +3.44% | -8.07% | -40.68% | 2.91TCr | |
| -0.46% | +4.55% | +48.18% | -7.29% | 2.32TCr | |
| +1.70% | -2.08% | -13.85% | -2.44% | 2.03TCr | |
| Average | -0.34% | +0.94% | +3.74% | -3.63% | 5.11TCr | |
| Weighted average by Cap. | -0.52% | -0.48% | -6.38% | -0.94% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 26Cr 22Cr 21Cr 19Cr 36Cr 2.46TCr 37Cr 243.56Cr 95Cr 1.2TCr 97Cr 95Cr 4.15TCr | 27Cr 24Cr 22Cr 20Cr 38Cr 2.59TCr 39Cr 255.78Cr 100Cr 1.26TCr 102.14Cr 100Cr 4.36TCr |
| Net income | 75.67L 65.35L 60.22L 56.37L 1.06Cr 72Cr 1.07Cr 7.11Cr 2.77Cr 35Cr 2.84Cr 2.78Cr 121.21Cr | 1.21Cr 1.05Cr 96.57L 90.39L 1.69Cr 115.33Cr 1.72Cr 11Cr 4.45Cr 56Cr 4.55Cr 4.46Cr 194.37Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/26/12 | 105.48 $ | -1.74% | 3,95,636 |
| 11/26/11 | 107.35 $ | +0.12% | 2,39,530 |
| 10/26/10 | 107.22 $ | -1.66% | 2,73,164 |
| 09/26/09 | 109.03 $ | +0.53% | 3,62,700 |
| 08/26/08 | 108.46 $ | +4.40% | 1,81,463 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MLAB Stock
Select your edition
All financial news and data tailored to specific country editions
